Start-up
Enhanc3D Genomics Ltd
About Enhanc3D Genomics
Enhanc3D Genomics was spun out from the laboratories of Dr. Stefan Schoenfelder and Professor Peter Fraser, who pioneered research into the dynamic spatial organisation of the genome at the Babraham Institute in Cambridge, UK.
Our mission is to unlock the full potential of the human genome’s 3D organisation for target and biomarker discovery.
Our proprietary GenLink3D platform uses capture Hi-C technologies to profile this 3D genome folding at high resolution for all genes and their enhancers simultaneously. The platform thus links gene enhancers and non-coding genetic variants to their target genes, unlocking their potential for therapeutic discovery; genetically supported drug targets are twice as likely to succeed in clinical trials (Sanseau et al., 2015).
- Founding: 2020
- Focus : Service
- Industry : Biotechnology, IT
Here you will find Enhanc3D Genomics Ltd
Last viewed contents
Enning Anlagentechnik Ges.mbH & Co KG - Recklinghausen, Germany
Carl_Robert_Ehrström
BGU researchers develop new fast test to tell bacterial and viral infections apart - Prof. Robert Marks and multi-disciplinary team tracked the immune system’s response to infection
Allon Therapeutics completes enrolment for Phase II Alzheimer's trial
Lithium_pharmacology
Tillotts Pharma AG - Ziefen, Switzerland
Allon enrolling patients in pivotal davunetide Phase 2/3 trial
Alcon and Amgen Sign Collaboration Agreement to Develop and Commercialize Innovative Therapies in Ophthalmology
Cornell researcher wins prestigious award for research on viruses that kill cancer cells
Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer
Amoxicillin
